Xvivo Perfusion AB (XVIPF)
29.39
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Xvivo Perfusion Shareholders Equity (Quarterly) : 227.73M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Getinge AB | 3.252B |
| Paxman AB | 42.89M |
| Enovis Corp. | 1.477B |
| Edwards Lifesciences Corp. | 10.33B |
| IDEXX Laboratories, Inc. | 1.556B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 259.18M |
| Total Liabilities (Quarterly) | 31.45M |
| Debt to Equity Ratio | 0.0566 |
| Current Ratio | 4.519 |
| Net Debt Paydown Yield | -0.27% |